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A consortium of institutions from Texas and
Mexico has launched a new initiative for
developing vaccines and other tools to control and
eliminate neglected tropical diseases in Mesoamer-
ica.
The southern United States and north-
ern Mexico not only share a border, they
also share history, culture, and language.
With its constant exchange of people and
goods, the US–Mexico border region (of
which Texas represents a large proportion)
can be considered a single, unique,
epidemiological unit with its own difficul-
ties and challenges. Although Mexico and
Texas have benefited from widespread
economic development and with it im-
provements in life expectancy and overall
public health, many diseases in a group of
infections known as the neglected tropical
diseases (NTDs) still remain highly en-
demic on both sides of the Texas–Mexico
border. The NTDs are the most common
infections of the poorest 120 million
people in the Americas who live on less
than US$2 per day [1]. They include
ancient scourges such as hookworm and
other soil-transmitted helminth infections,
Chagas disease, amoebiasis, schistosomia-
sis, vivax malaria, leishmaniasis, and
dengue [1]. Together, these NTDs pro-
duce a burden of disease in the western
hemisphere that in certain regions even
exceeds HIV/AIDS [1], while simulta-
neously trapping Latin America’s ‘‘bottom
100 million’’ in poverty through their
deleterious effects on child physical and
intellectual development, pregnancy out-
come, and worker productivity [2].
With the exception of schistosomiasis
and lymphatic filariasis, most of the major
NTDs found in Latin America are also
endemic to Mexico [3] (Table 1). Because
poverty is an overwhelming risk factor for
exposure to NTDs, the estimated 52
million people (46% of the population)
who live on less than 2,114 pesos (about
US$180) per month in urban areas or
1,329 pesos in rural areas and who lack at
least one basic social right suffer the
highest rates of these infections. The
estimated 11 million people (10% of the
population) who live in extreme poverty
(less than 978 pesos in urban areas, less
than 684 pesos in rural areas) and lacking
at least one social right [3] are especially
vulnerable [4]. Most of the NTDs occur in
Mexico’s poorest states, led by the contig-
uous southern states of Chiapas, Guerrero,
and Oaxaca [4]. Overall, these three
southern states, in addition to neighboring
Campeche, Quintana Roo, Veracruz, and
Yucatan, exhibit the lowest human devel-
opment indices in Mexico [5] (Figure 1).
Soil-transmitted helminth infections are
among the most common NTDs in
Mexico, led by trichuriasis (18 million
cases), ascariasis (9 million cases), hook-
worm infection (1 million cases), and
toxocariasis (number of cases not deter-
mined) [1,6]. In rural Chiapas, Necator
americanus hookworm infection is a signif-
icant cause of maternal-child anemia [7].
In addition, the incidence of cysticercosis,
a soil-transmitted platyhelminth infection
and a leading cause of epilepsy in Mexico,
has been estimated at 0.4 per 100,000
people, with most of the cases in the
southern states [5].
Equally important to Mexico are the
major vector-borne NTDs, led by up to six
million or more cases of Chagas disease
(American trypanosomiasis caused by
Trypanosoma cruzi), which are found pri-
marily in the states of Chiapas, Oaxaca,
Puebla, Veracruz, and Yucatan [8]. In
addition to transmission by triatomine
kissing bugs, both congenital infections
and transfusion-related T. cruzi infections
also occur [9]. Leishmaniasis is also
endemic. Cutaneous leishmaniasis (CL) is
responsible for 99% of the cases, mostly
caused by Leishmania mexicana [5]. CL is
hyperendemic in the state of Tabasco in
association with the cocoa industry there.
There are five possible vector species of
the genus Lutzomyia responsible for the
transmission of CL; Lutzomyia olmeca is the
predominant species on the Yucatan
peninsula and the incriminated vector in
the state of Tabasco for CL [10]. Visceral
leishmaniasis has also been reported
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20 years [5]. Unfortunately, most leish-
maniasis cases are still underreported in
Mexico. Vivax malaria is found predom-
inantly in the poorest states of Chiapas
and Oaxaca, as well as in Sinaloa,
Chihuahua, Durango, and Tabasco, al-
though only a small percentage of these
cases are reported [3,5]. Fewer than 3,000
cases of vivax malaria were reported in
Mexico in 2005 and 2009 (and less than
1,000 cases in 2011) [5]. Onchocerciasis is
traditionally endemic in three distinct foci
in Mexico, i.e., Oaxaca, northern Chia-
pas, and southern Chiapas [11,12], al-
though in 2010 it was reported that no
transmission has been detected in the first
two foci [11,12]. Dengue remains highly
endemic in Mexico [13], with dengue
virus type 2 (DENV-2) representing the
predominant serotype [5]. However, all
four serotypes of dengue are now present
in Mexico, due to reintroduction of
DENV-1 and DENV-4 from Central
America, and rates of severe dengue have
increased significantly since 2000 [5].
West Nile virus infection has also been
reported in Mexico [5].
Among the protozoan NTDs, amoebi-
asis and giardiasis are each widespread
enteric infections [14,15], and toxoplas-
mosis is an important protozoan infection
and a risk for pregnant women [16],
although national prevalence data are
not available for any of these conditions.
Brucellosis, leprosy, leptospirosis, and tra-
choma are the major bacterial NTDs [3].
The incidence of human brucellosis is two
to three cases per 100,000 people, with the
largest number in the states of Coahuila,
Nuevo Leon, Sinaloa, and Zacatecas,
mostly from contaminated milk and milk
products [5]. Mexico is one of three Latin
American countries (the others being
Brazil and Guatemala) with endemic
trachoma [17]. The disease is endemic in
five municipalities of Los Altos-Chiapas,
with a control program in place to search
for cases house by house [5]. The World
Health Organization reported 478 cases of
registered leprosy in Mexico at the end of
the first quarter of 2011 [18]. Canine
rabies is still reported in Mexico, with two
deaths from dog bites between 2000 and
2005 [5]. Overall, there is a need to
increase our understanding of the epide-
miology for NTDs in Mexico.
Across the border, the state of Texas is
neither immune to poverty nor to the
NTDs. Indeed, at a 17% poverty rate,
Texas has a significantly higher rate than
the overall 14% poverty rate in the United
States [19]. With 4.15 million people
living below the poverty line, Texas may
have the largest number of poor people of
any state in the US [19]. The poverty rates
are highest among Hispanic (26%) and
African-American minorities (23%) and
among children under the age of five (all
races) (28%) [19]. Poverty in Texas is
concentrated in South Texas, especially
along the border with Mexico (Figure 2).
Emerging evidence over the last few
years has revealed a hidden burden of
NTDs and related neglected infections of
poverty in Texas [20]. Among the hel-
minthic NTDs during the first half of the
20th century, hookworm infection was
hyperendemic in east Texas [21–23], with
prevalence rates as high as 84% in the
Piney Woods counties of Sabine, San
Augustine, Jasper, and Newton [21]. The
infection was found in association with
sandy soils present near rivers [21].
Hymenolepiasis was also determined to
be widespread during this period [21].
However, no studies of hookworm in
Texas have been reported in the last 50
years, and it is not known whether
hookworm or other intestinal helminth
infections such as ascariasis and trichuri-
asis remain endemic in the poorest rural
areas of east Texas. In contrast, it is now
well established that cysticercosis is a
leading cause of epilepsy among Hispanics
living in Texas [24,25]. Up to 169,000
cases of cysticercosis are estimated to
occur in the US, with Texas and Califor-
nia most likely representing the greatest
share of the disease burden from this
condition [20]. Toxocariasis, a zoonotic
larval helminth infection, is widespread
Table 1. The major NTDs of the Latin American and Caribbean region, Mexico, and Texas.
Disease
Estimated Number of Cases in Latin
America and the Caribbean [1,5]
Estimated Number of Cases
in Mexico [3,5,17,18] Disease Endemic to Texas?
Trichuriasis 100 million 18 million Unknown
Ascariasis 84 million 9 million Unknown
Hookworm 50 million 1 million Previously endemic
Amoebiasis Not determined 8–9 million Unknown
Chagas disease 8–9 million 2–6 million Yes – up to 267,000 cases
Schistosomiasis 2–7 million None None
Blinding trachoma 1.1 million ,1,000 None
Vivax malaria ,0.9 million reported cases in 2004 ,3,000 cases reported in 2005 and
2009; ,1,000 cases up to week 44 in 2011
a
None
Lymphatic filariasis 0.7 million None None
Dengue 0.5 million 27.2 cases per 100,000 Yes
Cysticercosis 0.4 million ,10,000 reported; incidence of 0.4 per 100,000 Yes
Leishmaniasis 67,000 ,10,000 reported Yes
Leprosy 33,953 registered cases 478 registered cases at the end of the
first quarter of 2011
Unknown
Brucellosis Not determined 24,000 reported; incidence of 2–3 per 100,000 Unknown
Leptospirosis Not determined Not determined Unknown
Onchocerciasis Near elimination Near elimination None
aThe number of cases of malaria in 2005 is published in [5]. These numbers were updated in 2009 in an unpublished report (Secretaria de Salud, Anuario de Morbilidad
2009, Mexico D.F., 2010) and up to week 44 in 2011 (Secretarı ´a de Salud, Boletin Epidemiologia, Semana 44, Mexico D.F., 2011).
doi:10.1371/journal.pntd.0001497.t001
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populations in the American South [20];
based on its prevalence among urban dogs
in Houston and presumably elsewhere
[26], it is likely that toxocariasis is also
widespread in Texas. This condition has
been linked to asthma and developmental
delays [27].
Several important vector-borne NTDs
have recently emerged in Texas, led by
Chagas disease, leishmaniasis, and dengue
[20]. Up to 267,000 cases of Chagas
disease are believed to occur in Texas
[28], although this figure may be an
overestimate [29]. The largest number of
US cases of Chagas disease may occur in
Texas as a result of human migrations
from Mexico in addition to autochthonous
transmission [30,31]. Infected vectors or
hosts are present in 82 of the 254 counties
of Texas [30]; they include wild zoonotic
reservoirs such as armadillos, coyotes,
raccoons, opossums, and rodents of the
genus Neotoma, canine reservoirs, and up to
11 species of kissing bugs, including three
major Triatoma species, i.e., Triatoma ger-
staeckeri, Triatoma sanguisuga, and Triatoma
leticulara [30,31]. Two major genotypes of
T. cruzi, i.e., TcI and TcIV, have been
reported from the US [31]. Although only
four cases of autochthonous infections
have been recorded in Texas [31], this
number is likely to be an underestimate of
the true number of cases [32], with the
additional possibility of congenital infec-
tions [9,31,33]. A risk analysis based on
the ecology and incidence of T. cruzi
infection among vectors and animal res-
ervoirs indicates that the greatest risk of
Chagas disease occurs in the south Texas
counties of Cameron, Nueces, Kleberg,
Hidalgo, Jim Wells, Willacy, Medina,
Dimmit, Frio, and Bandera, with expec-
tations of T. cruzi exposures and infections
among the major population centers in
Dallas, Houston, and San Antonio [30].
CL from L. mexicana infection (which is
transmitted by Lutzomyia sand flies) is
endemic in south-central Texas [34,35],
with at least nine autochthonous cases
reported from north Texas [36]. The
suspected (but unproven) vector for CL
in this area is Lutzomyia diabolica, but more
entomological and parasitological studies
are required to define the sand fly vector
species responsible for the transmission of
CL. Dengue is also endemic along the
border with Mexico, with an estimated 2%
seroprevalence in Brownsville [37]. The
major risk factors along the Texas–Mexico
border include low weekly family income,
absence of air conditioning and window
screens, and inadequate sanitation
[37,38]. Such conditions are found more
commonly across the border from Browns-
ville in Matamoros, Tamaulipas State,
Mexico, where the seroprevalence is
almost four times higher [37]. Of partic-
ular concern is the observation that a more
Figure 1. Poverty in Mexico by state. Map created by Usfirstgov with data from government website http://www.coneval.gob.mx/mapas/
NACIONAL/Nacional.pdf, accessed at http://en.wikipedia.org/wiki/File:Overall_Poverty.PNG March 7, 2012.
doi:10.1371/journal.pntd.0001497.g001
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dengue serotype 2 has been introduced
into the Texas–Mexico border area [39].
Approximately 100,000–200,000 cases of
dengue have been estimated to occur
among the Mexican-American population
in the US [20].
The high prevalence and incidence of
the major NTDs in both Mexico and
south Texas afford an opportunity for joint
cooperation to address the highest preva-
lence conditions, especially Chagas dis-
ease, CL, dengue, and the soil-transmitted
helminth infections. For each of these
NTDs there are widely disparate disease
estimates available, and this situation
suggests some urgency for programs of
active surveillance based on seropreva-
lence and other diagnostics studies. There
is an equally urgent need to determine the
major mechanisms of transmission, which
for Chagas disease would also include the
transmission from dogs and other canines,
estimates of the extent of congenital
infection, and the incidence of infection
acquired through blood transfusion. Such
efforts should include studies to screen for
congenital Chagas disease transmission in
hospitals with a high proportion of women
from Latin America [31]. Among the
recommendations recently suggested for
the control of Chagas disease in Texas is
the need to make Chagas disease report-
able (as it has been in Arizona and
Massachusetts [30]), to carry out serolog-
ical studies of human and canine popula-
tions, to monitor the extent of T. cruzi
infection in rodents and other wild zoo-
notic reservoirs, and to undertake wide-
spread testing of blood donors and other
at-risk populations [30]. Similar programs
of surveillance and transmission dynamics
are also required for CL, dengue, and
helminth infections [20]. Given the risks of
Chagas disease (including congenital Cha-
gas disease) in Mexico and the US, there is
an urgent need to educate cardiologists,
obstetricians, and other health care pro-
viders about the likelihood of this and
other neglected infections of poverty [31].
There is also an urgent need to develop
alternative control tools for the major
NTDs. Recently, the Instituto Carlos Slim
de la Salud (Carlos Slim Health Institute)
launched a joint US–Mexico initiative to
develop NTD vaccines, beginning with
Chagas disease and CL [2,40]. The
Iniciativa Slim para el desarollo de
vacunas contra enfermedades tropicales
(Slim Initiative for developing tropical
disease vaccines) is focusing its initial
efforts on developing a therapeutic vaccine
for Chagas disease with an emphasis on
Figure 2. Figure created at diy.net with data from US Census Bureau 2010 Small Area Income and Poverty Estimates accessed at http://www.census.
gov/did/www/saipe/county.html March 6, 2012.
doi:10.1371/journal.pntd.0001497.g002
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and TSA-1 [2,41], and a preventative CL
vaccine against L. mexicana infection com-
prised of a recombinant L. mexicana
nucleoside hydrolase [42–44] and a re-
combinant Lutzomyia sand fly salivary
antigen [45–47]. Such antigens would be
developed jointly by institutions based in
Texas and Mexico, in addition to the US
National Institutes of Health, with manu-
facture under cGMPs (current good man-
ufacturing practices) by Laboratorios de
Biolo ´gicos y Reactivos de Mexico (Birmex)
[48], the major biologics manufacturing
organization of the Mexican government.
In parallel, a newly established Section
of Pediatric Tropical Medicine at Texas
Children’s Hospital of Baylor College of
Medicine has linked with other institutions
within the Texas Medical Center and the
Sabin Vaccine Institute to develop vac-
cines and other appropriate technologies
for NTDs [49,50]. These organizations
provide the basis for a new National
School of Tropical Medicine recently
established at Baylor College of Medicine
[51,52]. Under the auspices of the Slim
Initiative, it is anticipated that these joint
activities might lead to a new generation of
NTD vaccines for hookworm, Chagas
disease, and leishmaniasis. Such technolo-
gies are sometimes referred to as ‘‘anti-
poverty vaccines’’ for their potential im-
pact to not only improve health, but also
to help lift Latin America’s bottom 100
million out of poverty [53,54]. Ultimately,
an all-out assault on the NTDs is necessary
if we hope to achieve elimination of these
ancient conditions in the coming decade.
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